Research article  

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

Teresa Puig, Helena Aguilar, Sílvia Cufí, Glòria Oliveras, Carlos Turrado, Sílvia Ortega-Gutiérrez, Bellinda Benhamú, María López-Rodríguez, Ander Urruticoechea, Ramon Colomer Breast Cancer Research 2011, 13:R131 (16 December 2011)

Abstract | Full text | PDF | PubMed

Research article  

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

Eleonor Olsson, Gabriella Honeth, Pär-Ola Bendahl, Lao H Saal, Sofia Gruvberger-Saal, Markus Ringnér, Johan Vallon-Christersson, Göran Jönsson, Karolina Holm, Kristina Lövgren, Mårten Fernö, Dorthe Grabau, Åke Borg, Cecilia Hegardt BMC Cancer 2011, 11:418 (29 September 2011)

Abstract | Full text | PDF | PubMed

Research  

Differential expression of HIF-1α in CD44⁺CD24^-/low breast ductal carcinomas

João Oliveira-Costa, Juliana S Zanetti, Giórgia G Silveira, Danilo F Soave, Lucinei R Oliveira, Verônica A Zorgetto, Fernando A Soares, Sérgio Zucoloto, Alfredo Ribeiro-Silva Diagnostic Pathology 2011, 6:73 (8 August 2011)

Abstract | Full text | PDF | PubMed

Research article  

The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7

Xin Fang, Hua Jiang, Xv Zhao, Wei Jiang BMC Cancer 2011, 11:290 (12 July 2011)

Abstract | Full text | PDF | PubMed

Review  

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression

Caitlin D May, Nathalie Sphyris, Kurt W Evans, Steven J Werden, Wenjun Guo, Sendurai A Mani Breast Cancer Research 2011, 13:202 (8 February 2011)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article  

Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines

Patricia J Keller, Amy F Lin, Lisa M Arendt, Ina Klebba, Ainsley D Jones, Jenny A Rudnick, Theresa A DiMeo , Hannah Gilmore, Douglas M Jefferson, Roger A Graham, Stephen P Naber, Stuart Schnitt, Charlotte Kuperwasser Breast Cancer Research 2010, 12:R87 (21 October 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Editorial  

Radiation resistance in breast cancer: are CD44⁺/CD24^-/proteosome^low/PKH26⁺ cells to blame?

Harikrishna Nakshatri Breast Cancer Research 2010, 12:105 (7 April 2010)

Abstract | Full text | PDF | PubMed

Research article  

Selective regain of egfr gene copies in CD44⁺/CD24^-/low breast cancer cellular model MDA-MB-468

Konstantin Agelopoulos, Burkhard Greve, Hartmut Schmidt, Heike Pospisil, Stefan Kurtz, Kai Bartkowiak, Antje Andreas, Marek Wieczorek, Eberhard Korsching, Horst Buerger, Burkhard Brandt BMC Cancer 2010, 10:78 (3 March 2010)

Abstract | Full text | PDF | PubMed

Editorial  

The more things change ... the more things change: developmental plasticity of tumor-initiating mammary epithelial cells

Michael T Lewis Breast Cancer Research 2009, 12:101 (18 January 2010)

Abstract | Full text | PDF

Research article  

Dynamic regulation of CD24 and the invasive, CD44^posCD24^neg phenotype in breast cancer cell lines

Matthew J Meyer, Jodie M Fleming, Mustapha A Ali, Mitchell W Pesesky, Erika Ginsburg, Barbara K Vonderhaar Breast Cancer Research 2009, 11:R82 (11 November 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review  

Epithelial to mesenchymal transition and breast cancer

Eva Tomaskovic-Crook, Erik W Thompson, Jean Thiery Breast Cancer Research 2009, 11:213 (9 November 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Primary research  

Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44^high/cd24^low population which is invasive and resistant to anoikis

Kelly J Gauger, Jeremy M Hugh, Melissa A Troester, Sallie Schneider Cancer Cell International 2009, 9:11 (7 May 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article  

Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide

Kannan Krishnamurthy, Guanghu Wang, Dmitriy Rokhfeld, Erhard Bieberich Breast Cancer Research 2008, 10:R106 (16 December 2008)

Abstract | Full text | PDF | PubMed

Case report  

A case of matrix-producing carcinoma of the breast

Toshiyuki Hirose, Junko Honda, Yoshimi Bando, Mitsunori Sasa, Yukiko Hirose, Taeko Nagao, Akira Tangoku World Journal of Surgical Oncology 2008, 6:60 (17 June 2008)

Abstract | Full text | PDF | PubMed

Research article  

The CD44⁺/CD24^- phenotype is enriched in basal-like breast tumors

Gabriella Honeth, Pär-Ola Bendahl, Markus Ringnér, Lao H Saal, Sofia K Gruvberger-Saal, Kristina Lövgren, Dorthe Grabau, Mårten Fernö, Åke Borg, Cecilia Hegardt Breast Cancer Research 2008, 10:R53 (17 June 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | Editor’s summary

Research article  

CD24 cross-linking induces apoptosis in, and inhibits migration of, MCF-7 breast cancer cells

Jong Kim, Eunyoung Ko, Wonshik Han, Jeong Lee, Kyung-Min Lee, Incheol Shin, Sangmin Kim, Jong Lee, Jihyoung Cho, Ji-Yeon Bae, Hyeon-Gun Jee, Dong-Young Noh BMC Cancer 2008, 8:118 (24 April 2008)

Abstract | Full text | PDF | PubMed

Editorial  

Cancer stem cell heterogeneity in hereditary breast cancer

Max S Wicha Breast Cancer Research 2008, 10:105 (16 April 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article  

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

Christine M Fillmore, Charlotte Kuperwasser Breast Cancer Research 2008, 10:R25 (26 March 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Viewpoint  

Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?

Christine Fillmore, Charlotte Kuperwasser Breast Cancer Research 2007, 9:303 (29 May 2007)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article  

Nectin-4 is a new histological and serological tumor associated marker for breast cancer

Stéphanie Fabre-Lafay, Florence Monville, Sarah Garrido-Urbani, Carole Berruyer-Pouyet, Christophe Ginestier, Nicolas Reymond, Pascal Finetti, Richard Sauvan, José Adélaïde, Jeannine Geneix, Eric Lecocq, Cornel Popovici, Patrice Dubreuil, Patrice Viens, Anthony Gonçalves, Emmanuelle Charafe-Jauffret, Jocelyne Jacquemier, Daniel Birnbaum, Marc Lopez BMC Cancer 2007, 7:73 (2 May 2007)

Abstract | Full text | PDF | PubMed